×
For best experience we recommend to activate Javascript in your browser.
ARHGDIB antibody (AA 2-201)
This Rabbit Polyclonal antibody specifically detects ARHGDIB in WB, IHC, IP and ICC. It exhibits reactivity toward Human.
Quick Overview for ARHGDIB antibody (AA 2-201) (ABIN7626286)
Target
See all ARHGDIB Antibodies
ARHGDIB
(rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))
Reactivity
All reactivities for ARHGDIB antibodies
Human
Host
All hosts for ARHGDIB antibodies
Rabbit
Clonality
All clonalities for ARHGDIB antibodies
Polyclonal
Conjugate
All conjugates for ARHGDIB antibodies
This ARHGDIB antibody is un-conjugated
Application
All applications for ARHGDIB antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-ARHGDIB Antibody
(hide)
Binding Specificity
All epitopes for ARHGDIB antibodies
AA 2-201
Purpose
Rho GDP Dissociation Inhibitor Beta (ARHGDIb) Polyclonal Antibody
Sequence
Thr2~Glu201
Characteristics
The Rho GDP Dissociation Inhibitor Beta (ARHGDIb) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for ARHGDIB
(hide)
Target
ARHGDIB
(rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))
Alternative Name
ARHGDIb
Gene ID
397
UniProt
P52566
Pathways
Caspase Cascade in Apoptosis
Recently viewed
(hide)
Chat with us , powered by LiveChat